CC BY-NC-ND 4.0 · Journal of Health and Allied Sciences NU 2015; 05(04): 077-079
DOI: 10.1055/s-0040-1703939
Case Report

A case of Fahr's syndrome with rare atypical presentation as hemiplegia

Venkata Ravikumar Chepuri
1   Assistant Professor, Department of Medicine, Rajiv Gandhi Institute of Medical Sciences [RIMS], Kadapa, Andhra Pradesh, India
,
Himabindu Panta
2   Post Graduate, Department of Medicine, Rajiv Gandhi Institute of Medical Sciences [RIMS], Kadapa, Andhra Pradesh, India
› Author Affiliations

Abstract

Calcification of basal ganglia or Fahr's disease is a rare disease characterized by bilateral and symmetrical intracranial deposition of calcium mainly in cerebral basal ganglia. Basal ganglia calcification secondary to endocrinological cause is known as Fahr's syndrome. Motor and neuropsychiatric symptoms are prominent features. We report a case presented with hemiplegia without any psychiatric symptoms. Radiological findings were suggestive of bilateral calcification of cerebellar hemispheres and basal ganglia. Parathyroid hormone levels were low with no significant findings in other investigations along with negative family history. Based on the radiological and biochemical findings the case was diagnosed as fahr's syndrome.



Publication History

Article published online:
22 April 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 Miller R. A Theory of the basal ganglia and their disorders. Boca Raton: CRC Press, Taylor & Francis;2008.
  • 2 Taxer F, Haller R, Konig P. Clinical early symptoms and CT findings in Fahr syndrome. Nervenarzt 1986;57:583-88.
  • 3 Ghormode D, Maheshwari U, Kate N, Grover S.Fahr's disease and psychiatric syndromes: A case series. Ind Psychiatr J 2011;20:136-8.
  • 4 Saleem et al. Fahr's syndrome. Literature review of current evidence.Orphanet Journal of Rare Diseases2013;8:156.
  • 5 Lauterbach EC, Cummings JL, Duffy J, Coffey CE, Kaufer D, Lovell M, et al. Neuropsychiatric correlates and treatment of lenticulostriatal diseases: A review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases. A report of the ANPA Committee on Research. American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci 1998;10:249-66.
  • 6 König P. Psychopathological alterations in cases of symmetrical basal ganglia sclerosis. Biol Psychiatry 1989;25:459-68.
  • 7 Faye AD, Gawande S, Tadke R, Kirpekar VC, Bhave SH. A case of psychosis due to Fahr's syndrome and response to behavioral disturbances with risperidone and oxcarbazepine. Indian J Psychiatry 2014;56:188-90.
  • 8 Manyam BV, Bhatt MH, Moore WD, Devleschoward AB, Anderson DR, Calne DB. Bilateral striopallidodentate calcinosis: Cerebrospinal fluid, imaging, and electrophysiological studies. Ann Neurol 1992;31:379 -84.
  • 9 Fenelon G, Gray F, Paillard F, Thibierge M, Mahieux F, Guillani A. A prospective study of patients with CT detected pallidal calcifications. JNeurolNeurosurgPsychiatry 1993;56:622–625.
  • 10 Shigeyuki O. Imaging of bilateral striopallidodentate calcinosis. Clin Nucl Med 2002;27:721–724.
  • 11 Modrego PJ, Mojonero J, Serrano M, Fayed N. Fahr's syndrome presenting with pure and progressive presenile dementia. NeurolSci2005;26:376–379.
  • 12 Saleem S, Aslam HM, Anwar M, et al. Fahr's syndrome: literature review of current evidence. Orphanet Journal of Rare Diseases. 2013;8:156.
  • 13 Gulsun M, Baykiz AF, Kabatas S, Belli H. Fahr's Syndrome—three casespresenting with psychiatric signs. Eur J Gen Med 2006;3:35–40.
  • 14 Senoglu M, Tuncel D, Orhan FO, Yuksel Z, Gokce M. Fahr's syndrome: a report of two cases. Firat Tip Dergisi 2007;12:70–72.